The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Innomed sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Innomed Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Innomed is a medical device company that manufactures surgical instruments for orthopedic surgery. The company’s products include retractors, bone hooks, elevators, patient positioners, surgical tools, charnley type tissue needle forceps, cheng biopsy trephine system, hannum grasper, incision aligner, mallet, grafting tools, and measuring aids. It also provides extractors, curettes, ortho caliper, ortho impactors, scissors, wire blender, screw removal, osteotomes, adjustable wrench, spreaders, cartilage grasper, cement packer and trimmers, among others. Innomed offers repair an warranty services. The company markets its products through a network of distributors located in Chile, Belgium, Australia, Argentina, India, Canada, Romania, the Netherlands, Austria, the Middle East, Japan. Innomed is headquartered in Savannah, Georgia, the US.

The key metrics of Innomed related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Innomed is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Innomed.

For a detailed understanding of the performance of Innomed, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.